Wockhardt files new fast-acting insulin with DCGI, shares surge 1 min read Markets Wockhardt files new fast-acting insulin with DCGI, shares surge Daily News Express October 16, 2024 Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory...Read More
